Fol. Biol. 2020, 66, 117-122

https://doi.org/10.14712/fb2020066040117

PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population

J. Karolova1,2, M. Radek1,3, K. Helman4, M. Spacek1,3, Marek Trněný1, Pavel Klener1,2

11st Department of Medicine, Department of Haematology, Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
2Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
3Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
4Faculty of Informatics and Statistics, University of Economics, Prague, Czech Republic

Received September 2020
Accepted November 2020

References

1. Adekambi, T., Ibegbu, C. C., Kalokhe, A. S., Yu, T., Ray, S. M., Rengarajan, J. (2012) Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One, 7, e36046. <https://doi.org/10.1371/journal.pone.0036046>
2. Andorsky, D. J., Yamada, R. E., Said, J., Pinkus, G. S., Betting, D. J., Timmerman, J. M. (2011) Programmed death ligand 1 is expressed by non–Hodgkin lymphomas and inhibits the activity of tumor-associated T cells. Clin. Cancer Res. 17, 4232-4244. <https://doi.org/10.1158/1078-0432.CCR-10-2660>
3. Brusa, D., Serra, S., Coscia, M., Rossi, D., D’Arena, G., Laurenti, L., Jaksic, O., Fedele, G., Inghirami, G., Gaidano, G., Malavasi, F., Deaglio, S., Deaglio, S. (2013) The PD-1/PDL1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica 98, 953-963. <https://doi.org/10.3324/haematol.2012.077537>
4. Elias, R., Karantanos, T., Sira, E., Hartshorn, K. L. (2017) Immunotherapy comes of age: Immune aging & checkpoint inhibitors. J. Geriatr. Oncol. 8, 229-235. <https://doi.org/10.1016/j.jgo.2017.02.001>
5. Elias, R., Hartshorn, K., Rahma, O., Lin, N., Snyder-Cappione, J. E. (2018) Aging, immune senescence and immunotherapy: a comprehensive review. Semin. Oncol. 45, 187-200. <https://doi.org/10.1053/j.seminoncol.2018.08.006>
6. Francisco, L. M., Sage, P. T., Sharpe, A. H. (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219-242. <https://doi.org/10.1111/j.1600-065X.2010.00923.x>
7. Gatalica, Z., Bilalovic, N., Vranic, S., Arguello, D., Reddy, S., Ghosh, N. (2015) PD-L1 and PD1 expression in lymphomas. Blood 126, 3899-3899. <https://doi.org/10.1182/blood.V126.23.3899.3899>
8. Grzywnowicz, M., Zaleska, J., Mertens, D., Tomczak, W., Wlasiuk, P., Kosior, K., Piechnik, A., Bojarska-Junak, A., Dmoszynska, A., Giannopoulos, K. (2012) Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia. PLoS One 7, e35178. <https://doi.org/10.1371/journal.pone.0035178>
9. Grzywnowicz, M., Karabon, L., Karczmarczyk, A., Zajac, M., Skorka, K., Zaleska, J., Wlasiuk, P., Chocholska, S., Tomczak, W., Bojarska-Junak, A., Dmoszynska, A., Frydecka, Giannopoulos, K. (2015) The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia. Leuk. Lymphoma 56, 2908-2913. <https://doi.org/10.3109/10428194.2015.1017820>
10. Harrington, B. K., Wheeler, E., Hornbuckle, K., Shana’ah, A. Y., Youssef, Y., Smith, L., Hassan Ii, Q., Klamer, B., Zhang, X., Long, M., Baiocchi, R.A., Maddocks, K., Johnson, A.J., Byrd, J.C., Alinari, L. (2019) Modulation of immune checkpoint molecule expression in mantle cell lymphoma. Leuk. Lymphoma 60, 2498-2507. <https://doi.org/10.1080/10428194.2019.1569231>
11. Jin, H. T., Ahmed, R., Okazaki, T. (2011) Role of PD-1 in regulating T-cell immunity. Curr. Top. Microbiol. Immunol. 350, 17-37.
12. Kalina, T., Flores-Montero, J., van der Velden, V. H., Martin- Ayuso, M., Bottcher, S., Ritgen, M., EuroFlow Consortium. (2012) EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 26, 1986-2010. <https://doi.org/10.1038/leu.2012.122>
13. Klener, P. (2019) Advances in molecular biology and targeted therapy of mantle cell lymphoma. Int. J. Mol. Sci. 20, <https://doi.org/10.3390/ijms20184417>
14. Menter, T., Bodmer-Haecki, A., Dirnhofer, S., Tzankov, A. (2016) Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Hum. Pathol. 54, 17-24. <https://doi.org/10.1016/j.humpath.2016.03.005>
15. Monteiro, M., Evaristo, C., Legrand, A., Nicoletti, A., Rocha, B. (2007) Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression. Blood 109, 2863-2870. <https://doi.org/10.1182/blood-2006-06-027060>
16. Muenst, S., Hoeller, S., Willi, N., Dirnhofera, S., Tzankov, A. (2010) Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Dis. Markers 29, 47-53. <https://doi.org/10.1155/2010/404069>
17. Nunes, C., Wong, R., Mason, M., Fegan, C., Man, S., Pepper, C. (2012) Expansion of a CD8+PD-1+ replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression. Clin. Cancer Res. 18, 678-687. <https://doi.org/10.1158/1078-0432.CCR-11-2630>
18. Riches, J. C., Davies, J. K., McClanahan, F., Fatah, R., Iqbal, S., Agrawal, S., Ramsay, A.G, Gribben, J. G. (2013) T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood 121, 1612-1621. <https://doi.org/10.1182/blood-2012-09-457531>
19. Shimatani, K., Nakashima, Y., Hattori, M., Hamazaki, Y., Minato, N. (2009) PD-1+ memory phenotype CD4+ T cells expressing C/EBPα underlie T cell immunodepression in senescence and leukemia. Proc. Natl. Acad. Sci. USA 106, 15807-15812. <https://doi.org/10.1073/pnas.0908805106>
20. Vranic, S., Ghosh, N., Kimbrough, J., Bilalovic, N., Bender, R., Arguello, D., Veloso, Y., Dizdarevic, A., Gatalica, Z. (2016) PD-L1 status in refractory lymphomas. PLoS One 11, e0166266. <https://doi.org/10.1371/journal.pone.0166266>
21. Wang, L., Qian, J., Lu, Y., Li, H., Bao, H., He, D., Liu, Z., Zheng, Y., He, J., Li, Y., Neelapu, S., Yang, J., Kwak, L.W., Yi, Q., Cai, Z. (2013) Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells. Haematologica 98, 1458-1466. <https://doi.org/10.3324/haematol.2012.071340>
22. Xerri, L., Chetaille, B., Serriari, N., Attias, C., Guillaume, Y., Arnoulet, C., Olive, D. (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and Bcell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum. Pathol. 39, 1050-1058. <https://doi.org/10.1016/j.humpath.2007.11.012>
23. Xu-Monette, Z. Y., Zhou, J., Young, K. H. (2018) PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood 131, 68-83. <https://doi.org/10.1182/blood-2017-07-740993>
24. Yang, J., Hu, G. (2019) Significance of PD-L1 in the diagnosis and treatment of B-cell malignant lymphoma. Oncol. Lett. 17, 3382-3386.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive